Menu
GWAS Study

Genome-wide association study identifies Alzheimer's risk variant in MS4A6A influencing cerebrospinal fluid sTREM2 levels.

Hou XH, Bi YL, Tan MS et al.

31204042 PubMed ID
GWAS Study Type
826 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

HX
Hou XH
BY
Bi YL
TM
Tan MS
XW
Xu W
LJ
Li JQ
SX
Shen XN
DK
Dou KX
TC
Tan CC
TL
Tan L
YJ
Yu JT
Chapter II

Abstract

Summary of the research findings

The triggering receptor expressed on myeloid cells 2 (TREM2) gene has been reported to increase the risk of Alzheimer's disease (AD). The soluble TREM2 protein (sTREM2) in cerebrospinal fluid (CSF) was also associated with AD. However, the role of sTREM2 in AD and its genetic modifiers remain unclear. We carried out a genome-wide association study for CSF sTREM2 levels using participants from the Alzheimer's Disease Neuroimaging Initiative and validated the significant association in an independent cohort from Chinese Alzheimer's Biomarker and LifestylE study. rs7232 in membrane spanning 4-domains A6A (MS4A6A) gene was associated with CSF sTREM2 levels at genome-wide significance (p = 1.42 × 10-15). The locus influences CSF sTREM2 levels especially in nondemented individuals. And the association was replicable in the validation cohort from Chinese Alzheimer's Biomarker and LifestylE study (p = 0.0106). Besides, the expressions of MS4A6A and TREM2 were correlated in brain regions (p < 2 × 10-16). The findings of our study suggest that the AD risk variant in the MS4A6A gene participates in the regulation of sTREM2.

449 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

826
Total Participants
GWAS
Study Type
Yes
Replicated
377 Han Chinese ancestry individuals
Replication Participants
European, East Asian
Ancestry
China
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.